Search research articles
Contact Us
Filters
Showing results (571-580 of 842) with videos related to
Page
of 85
Sort By:
Journal of Thrombosis and Thrombolysis
|
August 6, 2005
The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS)
David B Matchar, Alan K Jacobson, Robert G Edson, et al.
European Journal of Heart Failure
|
March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial
Justin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.
European Heart Journal
|
October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Journal of the American Heart Association
|
November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
Carolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.
Journal of Cardiac Failure
|
April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics
Barry M Massie, William F Krol, Susan E Ammon, et al.
Circulation
|
March 18, 2009
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
Barry M Massie, Joseph F Collins, Susan E Ammon, et al.
American Heart Journal
|
September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Circulation
|
June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation
Abhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)
Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.
Lancet (London, England)
|
April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Page
of 85
Search research articles
Search
Showing results (571-580 of 842) with videos related to
Sort By:
Page
of 85
Journal of Thrombosis and Thrombolysis
|
August 6, 2005
The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS)
David B Matchar, Alan K Jacobson, Robert G Edson, et al.
European Journal of Heart Failure
|
March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial
Justin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.
European Heart Journal
|
October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Journal of the American Heart Association
|
November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
Carolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.
Journal of Cardiac Failure
|
April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics
Barry M Massie, William F Krol, Susan E Ammon, et al.
Circulation
|
March 18, 2009
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
Barry M Massie, Joseph F Collins, Susan E Ammon, et al.
American Heart Journal
|
September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Circulation
|
June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation
Abhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)
Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.
Lancet (London, England)
|
April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Page
of 85